RushNet (RushNet) Research & Development : $ Mil (TTM As of . 20)

View and export this data going back to . Start your Free Trial

What is RushNet Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. RushNet's Research & Development for the three months ended in . 20 was $0.00 Mil. RushNet does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

RushNet Research & Development Historical Data

The historical data trend for RushNet's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RushNet Research & Development Chart

RushNet Annual Data

Trend

Research & Development

RushNet Quarterly Data

Research & Development

RushNet Research & Development Calculation

This is the expense the company spent on research and development.

RushNet (OTCPK:RSHN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

RushNet Research & Development Related Terms

Thank you for viewing the detailed overview of RushNet's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

RushNet (RushNet) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » RushNet Inc (OTCPK:RSHN) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

8465 Merchants Way, Suite 206, Orange Park, FL, USA, 32222

Website

https://www.rushnetinc.com

RushNet Inc through its subsidiary heliosDX, a National Clinical Reference Laboratory offers High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. The firm provides physicians individualized customer service, as well as fast and accurate reporting of results. The company invests in its infrastructure with the most efficient scientific proven instruments, and latest software for patient and physician satisfaction. It allows heliosDX to provide physicians fast and accurate reporting meeting. The firm excels in patient and client care through physician designed panels that aid in testing compliance and reporting education.